ulrich medical grows above industry average
The ulrich medical group reports that its revenue grew to €178 million in 2025. Its strategy of increasingly positioning itself internationally paid off it says, adding that with sales growth of 10 per cent it exceeds the average of the German medical technology industry.
In the spinal surgery product division, the uCentum Pro screw-rod system was successfully launched. The company says that strong growth in the radiology product division confirms the focus on customer needs and service combined with the advantages of ulrich medical technology in the contrast media injectors sector. It is taking this into account by investing in new capacity for production, with development of new capacity in radiology production underway.
CEO and chair Friedrich von Rechteren, commented: “Our strong focus on the needs of our customers and the flexibility to adapt to changing market requirements has resulted in above average growth rates for our company. For the current year, we also expect above-average growth, both in product division spine and in radiology, despite difficult global and national conditions.”
Picture: CEO and chair Friedrich von Rechteren
Read this report on page 5 of the June 2026 issue of RAD Magazine.
